Insights
There is always something exciting happening at Lockton. Here are just a few from our newsroom.
Zepbound outperforms Wegovy: What employers should know
The first clinical trial directly comparing weight-loss drugs Zepbound and Wegovy has confirmed previous placebo-controlled trial results indicating that adults taking Zepbound experience greater weight loss. According to Zepbound’s manufacturer Eli …
Avoiding coverage gaps in financial institutions’ insurance policies
In today’s digital-dependent landscape, financial institutions face a broad array of cyber threats that challenge their operational integrity and client trust. To address these risks, financial institutions often rely on a combination of directors an …
Healthcare organizations: Don’t wait for legislation to adopt cybersecurity best practices
Legislation proposed in late 2024 by a bipartisan group in the Senate would introduce broad new requirements that healthcare organizations invest in and better manage cybersecurity risks. Healthcare providers, however, should be more proactive in man …